This is important to so many moms and babies, it’s difficult to calculate.  This WebMD article announces the Food and Drug Administration’s agreement to allow women at risk for preterm birth (ie have had a previous preterm birth) to continue to receive shots of 17-Hydroxyprogesterone from compounding pharmacies for 15 to 20 bucks a pop.  The price of medicine had been set to increase to $1,500 because the FDA had approved KV Parmaceutical version - Makena -  and women using the compounding version would be forced to take the KV version.

This news caused many women taking weekly shots of  17 OHP to go into a full-on panic [Read more...]